Determinants of Post-COVID-19 Conditions among SARS-CoV-2-Infected Patients in Saudi Arabia: A Web-Based Cross-Sectional Study

被引:12
|
作者
Samannodi, Mohammed [1 ]
Alwafi, Hassan [2 ,3 ]
Naser, Abdallah Y. [4 ]
Al Qurashi, Abdullah A. [5 ,6 ]
Qedair, Jumanah T. [5 ,6 ]
Salawati, Emad [7 ]
Almatrafi, Mohammed A. [8 ]
Ekram, Rakan [9 ]
Bukhari, Rahaf, I [2 ]
Dahlawi, Maryam [2 ]
Hafiz, Bayan [2 ]
Mandora, Roaa [2 ]
Alsindi, Ranin K. [2 ]
Tayeb, Sarah [10 ]
Minshawi, Faisal [11 ]
机构
[1] Umm Al Qura Univ, Fac Med, Dept Med, Mecca 24382, Saudi Arabia
[2] Umm Al Qura Univ, Fac Med, Mecca 24382, Saudi Arabia
[3] Al Noor Specialist Hosp, Mecca 24241, Saudi Arabia
[4] Isra Univ, Fac Pharm, Dept Appl Pharmaceut Sci & Clin Pharm, Amman 11622, Jordan
[5] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah 22384, Saudi Arabia
[6] King Abdullah Int Med Res Ctr, Jeddah 22384, Saudi Arabia
[7] King Abdulaziz Univ, Fac Med, Dept Family Med, Jeddah 22254, Saudi Arabia
[8] Umm Al Qura Univ, Dept Pediat, Mecca 24382, Saudi Arabia
[9] Umm Al Qura Univ, Sch Publ Hlth & Hlth Informat, Mecca 24382, Saudi Arabia
[10] King Fahad Armed Forces Hosp, Dept Med, Jeddah 23311, Saudi Arabia
[11] Umm Al Qura Univ, Fac Appl Med Sci, Dept Lab Med, Mecca 24382, Saudi Arabia
关键词
novel coronavirus; acute COVID-19; post COVID-19 symptoms; RISK-FACTORS; INFECTION; COVID-19;
D O I
10.3390/diseases10030055
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Large numbers of people infected with COVID-19 developed acute symptoms. Post-COVID-19 conditions have been reported after recovery or discharge from the hospital. However, little is known about the prevalence and possible risk factors of post-COVID-19 conditions in the Saudi community. Here, we describe the incidence of post-COVID-19 conditions among the general population of Saudi Arabia. Methods: We conducted a cross-sectional, nationwide study using an online survey in Saudi Arabia from 1 September 2021 to 28 February 2022. The survey was distributed using social media platforms, such as Twitter, WhatsApp, and Facebook. Patients with SARS-CoV-2 infection were included in the questionnaire adapted from published studies. Result: The study enrolled 7520 individuals who were previously infected with SARS-CoV-2. Most patients in our study were symptomatic and their acute symptoms may persist for more than six days. On the other hand, long-term complications may develop and continue for an extended period (post-COVID-19 conditions). Most of these complications are respiratory, neurological, psychological, or skin related. The proportion of long-term complications reported in this study is 36% among SARS-CoV-2-infected individuals. In addition, being female, old age, number of chronic complications, long-term medication, length of stay in hospital and intensive care unit, and duration of acute symptoms may be significant predictors of post-COVID-19 symptoms. Conclusion: In conclusion, the incidence of post-COVID-19 conditions among the Saudi population was high, which urges further investigation into the risk factors associated with post-COVID-19 symptoms.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Post-COVID-19 Vaccination Infection Among Adults in Saudi Arabia: A Cross-Sectional Study
    Mohammed, Rehab A.
    Baqais, Omar
    Basalib, Samaher G.
    Owaidah, Abdulaziz A.
    Mirza, Abdulrahman
    Alharizi, Randa M.
    Sultan, Intessar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [2] COVID-19 Vaccine Hesitancy among Young Adults in Saudi Arabia: A Cross-Sectional Web-Based Study
    Almaghaslah, Dalia
    Alsayari, Abdulrhman
    Kandasamy, Geetha
    Vasudevan, Rajalakshimi
    VACCINES, 2021, 9 (04)
  • [3] Post COVID-19 Symptoms Among Infected Vaccinated Individuals: A Cross-Sectional Study in Saudi Arabia
    Adly, Heba M.
    Saleh, Saleh A. K.
    Garout, Mohammed A.
    Abdulkhaliq, Altaf A.
    Khafagy, Abdullah A.
    Saati, Abdullah A.
    Aljahdali, Imad A.
    Alandiyjany, Maher N.
    Al-Tawfiq, Jaffar A.
    JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2023, 13 (04) : 740 - 750
  • [4] Post COVID-19 Symptoms Among Infected Vaccinated Individuals: A Cross-Sectional Study in Saudi Arabia
    Heba M. Adly
    Saleh A. K. Saleh
    Mohammed A. Garout
    Altaf A. Abdulkhaliq
    Abdullah A. Khafagy
    Abdullah A. Saati
    Imad A. AlJahdali
    Maher N. Alandiyjany
    Jaffar A. Al-Tawfiq
    Journal of Epidemiology and Global Health, 2023, 13 : 740 - 750
  • [5] Musculoskeletal pain post-COVID-19 in patients undergoing physical therapy in Saudi Arabia: a cross-sectional study
    Ohoud S. Alnamlah
    Maha M. Almarwani
    BMC Musculoskeletal Disorders, 24
  • [6] Musculoskeletal pain post-COVID-19 in patients undergoing physical therapy in Saudi Arabia: a cross-sectional study
    Alnamlah, Ohoud S.
    Almarwani, Maha M.
    BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)
  • [7] Acceptability of COVID-19 vaccination in Saudi Arabia: A cross-sectional study using a web-based survey
    Alshahrani, Saeed Mastour
    Dehom, Salem
    Almutairi, Diaa
    Alnasser, Badr Saud
    Alsaif, Bandar
    Alabdrabalnabi, Ahmed A.
    Bin Rahmah, Abdullah
    Alshahrani, Mastour Safar
    El-Metwally, Ashraf
    Al-Khateeb, Badr F.
    Othman, Fatmah
    Mahtab Alam, Mohammad
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (10) : 3338 - 3347
  • [8] Prevalence and Predictors of Seasonal Influenza Vaccine Uptake in Saudi Arabia Post COVID-19: A Web-Based Online Cross-Sectional Study
    Alshahrani, Saeed Mastour
    Zahrani, Yousef
    VACCINES, 2023, 11 (02)
  • [9] Depression and related factors among patients with post-COVID-19 conditions: Cross-sectional, hospital-based study
    Binh, Nguyen Thanh
    Thuan, Tran Thien
    Luc, Nguyen Hoang Tan
    Bang, Ho Tat
    Trinh, Le Thi Diem
    HEALTH SCIENCE REPORTS, 2024, 7 (10)
  • [10] Perceived Telehealth Usability for Personalized Healthcare Among the Adult Population in Saudi Arabia: A Cross-Sectional Study in the Post-COVID-19 Era
    Sayed, Samiha Hamdi
    Aldailami, Danyah Abdulrahman
    Abd El Aziz, Maha Mahmoud
    Elsayed, Ebtesam Abbas
    HEALTHCARE, 2025, 13 (01)